سعر ايكساريتيك 20 مجم/2 مل 2025

Torsemide ampoule for intravenous injection, 20 mg/2 mL (Global Napi Pharmaceuticals); 3 ampoule(s) per pack.

• Oedema associated with heart failure, renal disease or hepatic diseasePopulation: AdultsDailyMed (US National Library of Medicine)
• HypertensionPopulation: AdultsDailyMed (US National Library of Medicine)

• Excessive urination most common in trials; post-marketing: pancreatitis, Stevens-Johnson syndrome/TEN, thiamine deficiency, among others.General active-ingredient information · DailyMed (US National Library of Medicine)

• Known hypersensitivity to torsemide or povidone; anuria; hepatic coma.General active-ingredient information · DailyMed (US National Library of Medicine)

• Hypotension and worsening renal function from excessive diuresis; fluid, electrolyte (hypokalaemia), glucose and uric acid disturbances - monitor; ototoxicity (tinnitus, hearing loss), especially at high doses or with other ototoxic drugs.General active-ingredient information · DailyMed (US National Library of Medicine)

• NSAIDs and salicylatesModerateMay reduce diuretic/natriuretic effect and increase risk of renal impairment; high-dose salicylates may cause salicylate toxicity.DailyMed (US National Library of Medicine)
• CYP2C9 inhibitors/inducers and substrates (e.g. warfarin, phenytoin)ModerateMay alter torsemide or substrate exposure; monitor.DailyMed (US National Library of Medicine)
• LithiumMajorReduced lithium clearance - risk of lithium toxicity; monitor lithium levels.DailyMed (US National Library of Medicine)

• No adequate human data; animal studies showed fetotoxicity only at high (maternally toxic) doses.General active-ingredient information · DailyMed (US National Library of Medicine)
• No data on torsemide in human milk; diuretics can suppress lactation.General active-ingredient information · DailyMed (US National Library of Medicine)

• Torsemide: Inhibits the Na+/K+/2Cl- carrier in the thick ascending limb of the loop of Henle.